Hijiya, N. Et Al. 2019. Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia. BLOOD , vol.134, no.23 , 2036-2045.

Hijiya, N., Maschan, A., Rizzari, C., Shimada, H., Dufour, C., Goto, H., ... Kang, H. J.(2019). Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia. BLOOD , vol.134, no.23, 2036-2045.

Hijiya, Nobuko Et Al. "Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia," BLOOD , vol.134, no.23, 2036-2045, 2019

Hijiya, Nobuko Et Al. "Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia." BLOOD , vol.134, no.23, pp.2036-2045, 2019

Hijiya, N. Et Al. (2019) . "Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia." BLOOD , vol.134, no.23, pp.2036-2045.

@article{article, author={Nobuko Hijiya Et Al. }, title={Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia}, journal={BLOOD}, year=2019, pages={2036-2045} }